Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 4 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCRecruitingNCT04342910Phase 3
• A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLCRecruitingNCT04316364Phase 3
• A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationRecruitingNCT04296370Phase 3
• A Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT04162899Phase 2Results posted
• A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCCCompletedNCT03764293Phase 3Results posted
• A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue SarcomaTerminatedNCT03711279Phase 2Results posted
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.CompletedNCT03675477Phase 2Results posted
• SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.CompletedNCT03558191Phase 2Results posted
• A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric CancerCompletedNCT03472365Phase 2Results posted
• A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)CompletedNCT03463876Phase 2Results posted
• SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard TherapyCompletedNCT03417895Phase 2Results posted
• PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's LymphomaCompletedNCT03155425Phase 2Results posted
• Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal CancerCompletedNCT03099382Phase 3Results posted
• A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTCCompletedNCT03092895Phase 2Results posted
• A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)CompletedNCT03083041Phase 2Results posted
• A Study to Evaluate SHR-1210 in Subjects With Advanced HCCCompletedNCT02989922Phase 2Results posted
• Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)CompletedNCT02329860Phase 3Results posted
• Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerCompletedNCT01512745Phase 3Results posted
• The Safety and Efficacy of HR19034 in Children With MyopiaCompletedNCT07844356Phase 2/3
• A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisActive, not recruitingNCT07688772Phase 3
• A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy ParticipantsActive, not recruitingNCT07681479Phase 1
• A Clinical Study Comparing the Bioavailability of HRS-2189 TabletsCompletedNCT07639905Phase 1
• A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy ParticipantsActive, not recruitingNCT07610148Phase 1
• A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy ParticipantsCompletedNCT07608705Phase 1
• To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy SubjectsCompletedNCT07588906Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With ObesityActive, not recruitingNCT07559136Phase 1
• Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy ParticipantsActive, not recruitingNCT07494175Phase 1
• A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy ParticipantsCompletedNCT07479641Phase 1
• A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic AgentsActive, not recruitingNCT07472725Phase 2
• A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary AldosteronismActive, not recruitingNCT07470983Phase 2
• Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in AdultsCompletedNCT07446309Phase 2
• Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in AdultsCompletedNCT07404579Phase 2
• A Trial of SHR-2173 in Healthy VolunteersCompletedNCT07390747Phase 1
• A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)CompletedNCT07372924Phase 2
• A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee OsteoarthritisCompletedNCT07351968Phase 1
• A Study of SHR-1918 In Participants With HypertriglyceridemiaActive, not recruitingNCT07349615Phase 3
• A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney FunctionCompletedNCT07322016Phase 1
• A Study of SHR-1819 in Patients With Moderate-to-severe Atopic DermatitisActive, not recruitingNCT07321951Phase 2
• A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.CompletedNCT07320521Phase 1
• Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute PancreatitisActive, not recruitingNCT07308392Phase 2
• A Study of Single and Multiple Doses of HRS-6257 in Healthy SubjectsCompletedNCT07301333Phase 1
• Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate HypertensionActive, not recruitingNCT07297797Phase 2
• A Clinical Study of RSS0343 in Healthy SubjectsCompletedNCT07289464Phase 1
• A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With ObesityActive, not recruitingNCT07285902Phase 3
• A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple DosesActive, not recruitingNCT07280936Phase 1
• A Study on the Bioequivalence of Bupivacaine Liposome Injection in HumansCompletedNCT07279155Phase 1
• A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) LesionsCompletedNCT07275814Phase 3
• A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) LesionsCompletedNCT07275723Phase 3
• A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy SubjectsCompletedNCT07272330Phase 1
• A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsCompletedNCT07269756Phase 1
• A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy SubjectsCompletedNCT07264335Phase 1
• Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in AdultsCompletedNCT07252921Phase 2
• A Trial of HRS-5817 in Obese ParticipantsActive, not recruitingNCT07238647Early Phase 1
• A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid ArthritisActive, not recruitingNCT07233655Phase 2
• HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.CompletedNCT07233070Phase 2
• Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple AdministrationCompletedNCT07232758Phase 1
• A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative ColitisActive, not recruitingNCT07232576Phase 2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic EnzymesCompletedNCT07230418Phase 1
• Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy SubjectsCompletedNCT07229716Phase 1
• A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy ParticipantsCompletedNCT07229560Phase 1
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy SubjectsCompletedNCT07200596Phase 1
• A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast CancerActive, not recruitingNCT07196774Phase 3
• A Single Ascending Dose of HRS-2162 in Healthy SubjectsCompletedNCT07195604Phase 1
• A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy ParticipantsCompletedNCT07189962Phase 1
• A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsActive, not recruitingNCT07185776Phase 2
• A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLCActive, not recruitingNCT07183189Phase 3
• A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic DermatitisCompletedNCT07158151Phase 2
• A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy AdultsCompletedNCT07142850Phase 1
• Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy SubjectsCompletedNCT07123376Phase 1
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study.CompletedNCT07117474Phase 1
• A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.CompletedNCT07116915Phase 1
• Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343CompletedNCT07101965Phase 1
• A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With HyperlipidemiaActive, not recruitingNCT07100418Phase 2
• A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy SubjectsCompletedNCT07098117Phase 1
• A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy SubjectsCompletedNCT07097831Phase 1
• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT07091357Phase 2
• Safety, Tolerability and Pharmacokinetic Study of HRS-8829CompletedNCT07083362Phase 1
• A Trial of SHR-1139 in Healthy VolunteersActive, not recruitingNCT07078695Phase 1
• A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy SubjectsCompletedNCT07076459Phase 1
• Effect of HRS-8427 for Injection on the Pharmacokinetics of Furosemide and Metformin in Healthy Subjects。CompletedNCT07073157Phase 1
• A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal CancerActive, not recruitingNCT07071714Phase 2
• Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal FunctionCompletedNCT07070375Phase 1
• A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque PsoriasisCompletedNCT07051538Phase 1
• Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese SubjectsCompletedNCT07049562Phase 1
• Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy SubjectsCompletedNCT07049107Phase 1
• Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy SubjectsCompletedNCT07040787Phase 1
• A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent PatientsCompletedNCT07036419Phase 2/3
• A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy SubjectsCompletedNCT07035665Phase 1
• A Trial of HRS-1893 in Healthy VolunteersCompletedNCT07033455Early Phase 1
• A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic CardiomyopathyActive, not recruitingNCT07021976Phase 3
• A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic DrugsActive, not recruitingNCT07018453Phase 2
• A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy SubjectsCompletedNCT07014488Phase 1
• A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung CancerActive, not recruitingNCT07009457Phase 1
• Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy SubjectsCompletedNCT06995001Phase 1
• A Phase I Study of SHR-4712 in Patients With Advanced Solid TumorsActive, not recruitingNCT06993116Phase 1
• Relative Bioavailability Study of HRG2010 in Healthy SubjectsCompletedNCT06976346Phase 1
• A Trial of SHR7280 in Healthy SubjectsCompletedNCT06969664Phase 1
• Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT06961643Phase 1
• A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus ErythematosusCompletedNCT06955598Phase 1
• A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy SubjectsCompletedNCT06949124Phase 1

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas